Growth hormone resistance in beta cells after pregnancy
Part of Hormones & metabolism, Women’s health & pregnancy clinical trials.
This study looks at how the body's insulin-making cells (beta cells) might become resistant to growth hormone after a full-term pregnancy. It compares women who had gestational diabetes to those who didn't, to learn more about diabetes risk. You may join if you had a healthy single-baby pregnancy in the last 5 years and never had type 1 or type 2 diabetes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You had a single baby, full-term pregnancy within the last 5 years
- Your body mass index (BMI) is between 18.5 and 45
- You are not pregnant, planning to become pregnant soon, or breastfeeding
- You do not have or have never had type 1 or type 2 diabetes
- You have no first-degree relative (parent, sibling, child) with diabetes
- You do not smoke more than 2 cigarettes a day and do not have an alcohol or drug use problem
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how growth hormone affects insulin-making cells in people at risk for type 2 diabetes. It may help explain why some people with a family history of diabetes develop the condition.
This study looks at how growth hormone affects the cells in your pancreas that make insulin. It may help find new ways to prevent type 2 diabetes in people with prediabetes.
This trial looks at gestational diabetes (high blood sugar during pregnancy) and may study how it’s managed during pregnancy and postpartum. It may help researchers understand what approaches are safe and useful for people with this condition.
This study follows pregnant people to understand gestational diabetes (high blood sugar during pregnancy) and how it shows up and is monitored. It may help improve future screening and care for gestational diabetes.
This study compares a tighter blood sugar goal versus a standard goal in pregnant people with gestational diabetes who are also overweight or obese. It may help find whether stricter blood sugar control improves pregnancy outcomes.
This study tests whether using a continuous glucose monitor (a small sensor that tracks your blood sugar) along with support from others can help prevent or manage high blood sugar during pregnancy. It is for pregnant women under 20 weeks who have certain risk factors for gestational diabetes.
Hear when a new Gestational Diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.